The brain-derived neurotrophic factor prompts platelet aggregation and secretion
dc.contributor.author | Boukhatem, Imane | |
dc.contributor.author | Fleury, Samuel | |
dc.contributor.author | Welman, Mélanie | |
dc.contributor.author | Le Blanc, Jessica | |
dc.contributor.author | Thys, Chantal | |
dc.contributor.author | Freson, Kathleen | |
dc.contributor.author | Best, Myron G. | |
dc.contributor.author | Würdinger, Thomas | |
dc.contributor.author | Allen, Bruce G. | |
dc.contributor.author | Lordkipanidzé, Marie | |
dc.date.accessioned | 2021-09-23T15:43:17Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2021-09-23T15:43:17Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.uri | http://hdl.handle.net/1866/25744 | |
dc.publisher | American Society of Hematology | fr |
dc.title | The brain-derived neurotrophic factor prompts platelet aggregation and secretion | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de pharmacie | fr |
dc.identifier.doi | 10.1182/bloodadvances.2020004098 | |
dcterms.abstract | Brain-derived neurotrophic factor (BDNF) has both autocrine and paracrine roles in neurons, and its release and signaling mechanisms have been extensively studied in the central nervous system. Large quantities of BDNF have been reported in circulation, essentially stored in platelets with concentrations reaching 100- to 1000-fold those of neurons. Despite this abundance, the function of BDNF in platelet biology has not been explored. At low concentrations, BDNF primed platelets, acting synergistically with classical agonists. At high concentrations, BDNF induced complete biphasic platelet aggregation that in part relied on amplification from secondary mediators. Neurotrophin-4, but not nerve growth factor, and an activating antibody against the canonical BDNF receptor tropomyosin-related kinase B (TrkB) induced similar platelet responses to BDNF, suggesting TrkB could be the mediator. Platelets expressed, both at their surface and in their intracellular compartment, a truncated form of TrkB lacking its tyrosine kinase domain. BDNFinduced platelet aggregation was prevented by inhibitors of Ras-related C3 botulinum toxin substrate 1 (Rac1), protein kinase C, and phosphoinositide 3-kinase. BDNF-stimulated platelets secreted a panel of angiogenic and inflammatory cytokines, which may play a role in maintaining vascular homeostasis. Two families with autism spectrum disorder were found to carry rare missense variants in the BDNF gene. Platelet studies revealed defects in platelet aggregation to low concentrations of collagen, as well as reduced adenosine triphosphate secretion in response to adenosine diphosphate. In summary, circulating BDNF levels appear to regulate platelet activation, aggregation, and secretion through activation of a truncated TrkB receptor and downstream kinase-dependent signaling. | fr |
dcterms.isPartOf | urn:ISSN:2473-9529 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | PMID: 34546355 | fr |
UdeM.VersionRioxx | Version publiée / Version of Record | fr |
oaire.citationTitle | Blood advances | fr |
oaire.citationVolume | 5 | fr |
oaire.citationIssue | 18 | fr |
oaire.citationStartPage | 3568 | fr |
oaire.citationEndPage | 3580 | fr |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.